Clinical Trials Browser

Phase 1/2 × Not yet recruiting × Leukemia, Lymphocytic, Chronic, B-Cell × Clear all

NCT06979076 2025-09-29

A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed CLL/SLL

Phase 1/2 Not yet recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell